Your browser doesn't support javascript.
loading
Lactic Acid Bacteria as Delivery Vehicle for Therapeutics Applications.
Batista, Viviane Lima; da Silva, Tales Fernando; de Jesus, Luis Cláudio Lima; Tapia-Costa, Ana Paula; Drumond, Mariana Martins; Azevedo, Vasco; Mancha-Agresti, Pamela.
Afiliação
  • Batista VL; Laboratory of Cellular and Molecular Genetics (LGCM), Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • da Silva TF; Laboratory of Cellular and Molecular Genetics (LGCM), Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • de Jesus LCL; Laboratory of Cellular and Molecular Genetics (LGCM), Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • Tapia-Costa AP; Biomedical Science Institute (ICBM), Catholic of Cuyo University, San Juan, CP, Argentina.
  • Drumond MM; Laboratory of Cellular and Molecular Genetics (LGCM), Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
  • Azevedo V; Department of Biological Sciences, Federal Center for Technological Education of Minas Gerais (CEFET/MG), Belo Horizonte, Minas Gerais, Brazil.
  • Mancha-Agresti P; Laboratory of Cellular and Molecular Genetics (LGCM), Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
Methods Mol Biol ; 2183: 447-459, 2021.
Article em En | MEDLINE | ID: mdl-32959259
ABSTRACT
Lactic acid bacteria comprise a large group of Gram-positive organisms capable of converting sugar into lactic acid. They have been studied due to their therapeutic potential on the mucosal surface. Among the species, Lactococcus lactis is considered the model bacterium and it has been explored as an important vehicle for providing therapeutic molecules and antigens in the mucosa. They can be genetically engineered to produce a variety of molecules as well as deliver heterologous DNA and protein. DNA vaccines consist of the administration of a bacterial plasmid under the control of a eukaryotic promoter encoding the antigen of interest. The resulting proteins are capable of stimulating the immune system, becoming a promising technique for immunization against a variety of tumors and infection diseases and having several advantages compared to conventional nucleic acid delivery methods (such as bioballistic delivery, electroporation, and intramuscular administration).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Sistemas de Liberação de Medicamentos / Técnicas de Transferência de Genes / Vacinas de DNA / Lactobacillales Limite: Animals Idioma: En Revista: Methods Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Sistemas de Liberação de Medicamentos / Técnicas de Transferência de Genes / Vacinas de DNA / Lactobacillales Limite: Animals Idioma: En Revista: Methods Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil